Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China
· Delayed Price · Currency is CNY 38.34
-0.25 (-0.65%)
Apr 29, 2026, 3:04 PM CST
Lifecome Biochemistry Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,959 | 5,239 | 3,104 | 3,261 | 8,144 | 1,692 | Upgrade
|
| Market Cap Growth | 139.03% | 68.80% | -4.84% | -59.96% | 381.32% | -17.32% | Upgrade
|
| Enterprise Value | 6,236 | 6,325 | 4,110 | 3,952 | 8,399 | 1,846 | Upgrade
|
| Last Close Price | 38.34 | 33.71 | 19.97 | 21.26 | 53.09 | 11.03 | Upgrade
|
| PS Ratio | 11.85 | 10.14 | 4.78 | 6.43 | 24.69 | 4.66 | Upgrade
|
| PB Ratio | 83.79 | 80.69 | -126.49 | 7.88 | 13.59 | 2.34 | Upgrade
|
| P/TBV Ratio | 122.29 | 124.44 | - | 15.00 | 14.43 | 2.50 | Upgrade
|
| P/FCF Ratio | - | - | 189.81 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 21.95 | - | - | 48.11 | Upgrade
|
| EV/Sales Ratio | 12.40 | 12.24 | 6.33 | 7.80 | 25.46 | 5.08 | Upgrade
|
| EV/EBITDA Ratio | 136.83 | 557.77 | - | - | - | 92.74 | Upgrade
|
| EV/FCF Ratio | -38.95 | - | 251.38 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 5.22 | 7.82 | -38.70 | 2.62 | 0.66 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 7.84 | 35.37 | - | - | - | 16.07 | Upgrade
|
| Debt / FCF Ratio | - | - | 58.08 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 3.87 | 6.96 | -37.69 | 2.42 | 0.62 | 0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | 6.21 | 39.85 | -8.12 | -8.17 | -7.07 | 11.24 | Upgrade
|
| Net Debt / FCF Ratio | -1.72 | -2.92 | 56.56 | -1.54 | -2.54 | -0.69 | Upgrade
|
| Asset Turnover | 0.45 | 0.46 | 0.38 | 0.32 | 0.26 | 0.33 | Upgrade
|
| Inventory Turnover | 5.03 | 5.24 | 5.08 | 4.21 | 5.08 | 5.43 | Upgrade
|
| Quick Ratio | 0.38 | 0.18 | 0.10 | 0.29 | 0.18 | 0.42 | Upgrade
|
| Current Ratio | 0.58 | 0.35 | 0.17 | 0.51 | 1.04 | 0.58 | Upgrade
|
| Return on Equity (ROE) | -1189.13% | -689.73% | -228.96% | -43.93% | -18.57% | -3.55% | Upgrade
|
| Return on Assets (ROA) | -2.81% | -4.66% | -7.62% | -7.49% | -5.84% | -0.78% | Upgrade
|
| Return on Invested Capital (ROIC) | -11.58% | -11.78% | -18.19% | -16.08% | -12.18% | -1.74% | Upgrade
|
| Return on Capital Employed (ROCE) | -14.10% | -55.10% | -84.70% | -18.60% | -15.50% | -1.60% | Upgrade
|
| Earnings Yield | -1.74% | -2.66% | -14.33% | -6.80% | -1.50% | -1.54% | Upgrade
|
| FCF Yield | -2.69% | -2.96% | 0.53% | -19.97% | -1.80% | -19.03% | Upgrade
|
| Buyback Yield / Dilution | 0.54% | 0.52% | -0.98% | 0.20% | -0.75% | 0.72% | Upgrade
|
| Total Shareholder Return | 0.54% | 0.52% | -0.98% | 0.20% | -0.75% | 0.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.